Idexx Laboratories Share Price (NASDAQ: IDXX)
$641.22
▲
0.36
(0.06%)
Live
Last updated on
Check the interactive Idexx Laboratories Stock chart to analyse performance
Idexx Laboratories, Inc. Key Stats
Check Idexx Laboratories key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Idexx Laboratories Stock including INR - Dollar returns
The Idexx Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Idexx Laboratories investment value today
Current value as on today
₹1,37,607
Returns
₹37,607
(+37.61%)
Returns from Idexx Laboratories Stock
₹33,177 (+33.18%)
Dollar Returns*
₹4,430 (+4.43%)
Indian investors sentiment towards Idexx Laboratories Stock
Indian Mutual Funds that invest in Idexx Laboratories Stock
| Name | Shares Held | Change in Shares | % of Assets |
|---|---|---|---|
 | 650 | 2.03 | 0.08% |
 | 1144 | 3.90 | 0.24% |
Global Institutional Holdings in Idexx Laboratories, Inc.
Name
Holdings %
Vanguard Group Inc
12.34%
BlackRock Inc
10.88%
State Street Corp
4.56%
Fundsmith LLP
3.30%
Geode Capital Management, LLC
3.01%
BAMCO Inc
2.54%
Analyst Recommendation on Idexx Laboratories Stock
Buy
68%Buy
31%Hold
0%Sell
Based on 19 Wall street analysts offering stock ratings for Idexx Laboratories(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Idexx Laboratories Share Price Target
What analysts predicted
Upside of 8.4%
Target:
$695.09
Current:
$641.22
Idexx Laboratories share price target is $695.09, a slight Upside of 8.4% compared to current price of $641.22 as per analysts' prediction.
Idexx Laboratories Stock Insights
Price Movement
In the last 1 month, IDXX stock has moved up by 13.1%Increasing Revenue
Idexx Laboratories, Inc. has shown positive revenue growth, with an increase for the last three quarters. The revenue has risen from $954.28 million to $1.10 billion, resulting in an average quarterly growth of 7.2%.Increasing Net Profit
Idexx Laboratories, Inc. has shown a positive trend in its net profit over the last three quarters. The net profit increased from $216.14 million to $293.98 million, averaging a rise of 14.2% each quarter.
Idexx Laboratories, Inc. Financials
Idexx Laboratories Technicals Summary
Sell
Neutral
Buy
Idexx Laboratories is currently in a neutral trading position according to technical analysis indicators.
Idexx Laboratories, Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 11.83% | 45.31% | 33.1% | 83.6% | 63.88% |
 | -0.96% | -6.6% | -15.86% | -7.35% | 18.19% |
 | 1.24% | -6.71% | -20.39% | -12.32% | 13.79% |
 | -0.89% | -0.35% | -22.95% | -25.91% | -0.71% |
 | -2.96% | 1.23% | -23.73% | -13.48% | 15.3% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 53.52 | 53.52 | 4.8 | 12.6 | 0.65 | 0.23 | NA | 18.2 |
| 29.23 | 29.23 | 1.74 | 5.58 | 0.19 | 0.08 | 0.01 | 21.61 |
| 28.28 | 28.28 | 1.99 | 22.49 | 0.13 | 0.05 | 0.0 | 133.77 |
| 43.88 | 43.88 | 2.07 | 7.77 | 0.07 | 0.04 | 0.01 | 73.1 |
| 27.4 | 27.4 | 1.08 | 11.87 | 0.2 | 0.05 | NA | 33.99 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $51.3B | 63.88% | 53.52 | 24.41% |
| Buy | $33.7B | 18.19% | 29.23 | 17.59% |
| Buy | $184.5B | 13.79% | 28.28 | 15.24% |
| Buy | $147.7B | -0.71% | 43.88 | 14.21% |
| Buy | $32.1B | 15.3% | 27.4 | 7.88% |
About Idexx Laboratories, Inc.
Key Management of Idexx Laboratories, Inc.
Important FAQs about investing in IDXX Stock from India :
What is Idexx Laboratories share price today?
Idexx Laboratories share price today is $641.22 as on . Idexx Laboratories share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Idexx Laboratories share?
Idexx Laboratories share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Idexx Laboratories stock price today i.e. is trending at $641.22, lower by 0% versus the 52 week high.
How to invest in Idexx Laboratories Stock (IDXX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Idexx Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Idexx Laboratories Shares that will get you 0.0023 shares as per Idexx Laboratories share price of $641.22 per share as on August 29, 2025 at 12:39 am IST.
What is the minimum amount required to buy Idexx Laboratories Stock (IDXX) from India?
Indian investors can start investing in Idexx Laboratories (IDXX) shares with as little as ₹87.6463 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.46 in Idexx Laboratories stock (as per the Rupee-Dollar exchange rate as on August 28, 2025).
Based on Idexx Laboratories share’s latest price of $641.22 as on August 29, 2025 at 12:39 am IST, you will get 0.0156 shares of Idexx Laboratories. Learn more about
fractional shares .
What are the returns that Idexx Laboratories has given to Indian investors in the last 5 years?
Idexx Laboratories stock has given 63.88% share price returns and 18.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Evergy, Inc$71.37
-0.96%
Liberty Media Corp-liberty-a$94.32
+0.6%
Site Centers Corp.$12.16
-0.73%
Royalty Pharma Plc$35.64
-1.16%
Airbnb$130.39
+0.42%
Edison International$54.84
-0.98%
Deckers Outdoor Corp.$117.58
+0.73%
O'reilly Automotive Inc.$103.72
-0.32%
Parker-hannifin Corporation$764.51
-0.47%